Case number 1:18-cv-01040
Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries, Ltd., et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 11, 2022 | 40 | Patent/Trademark Report to Commissioner (4) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Apr 11, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 800 in lead case no. 18-1043-KAJ) (ntl) |
| Apr 1, 2022 | 39 | Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Joint Status Report - re (38 in 1:18-cv-01040-LPS) Order, (55 in 1:18-cv-01038-LPS) Order,. (Silver, Daniel) |
| Mar 29, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: The Court observes that this case is marked as related to one or more other cases now pending before another judge of this Court. Accordingly, IT IS HEREBY ORDERED that the parties shall meet and confer and, no later than April 1, submit a joint status report, providing their position(s) as to which judge this case should be reassigned to. ORDERED by Judge Leonard P. Stark on 3/29/22. (ntl) |
| Mar 29, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-01038-LPS et al. (ntl) |
| Oct 19, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 38 proposed judgment was removed from the docket per request of counsel. (ntl) |
| Dec 13, 2018 | 37 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants Consolidated Invalidity Contentions Regarding U.S. Patent No. 9,187,405 filed by HEC Pharm Co., Ltd., HEC Pharm USA Inc..(Stamoulis, Stamatios) |
| Oct 26, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01043-LPS. (ntl) |
| Oct 25, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' most recent submission relating to scheduling and the protective order (see C.A. No. 18-1038 D.I. 47), and considering the parties' earlier related submissions and the Court's discussion of the issues with the parties on October 16, the Court will today be docketing the scheduling order, protective order, and ESI order to govern these cases. The Court has exercised its discretion in the fashion it believes most reasonable to all involved, balancing important competing interests on each side. In particular, with respect to scheduling: the Court agrees with Novartis that there should be some time limit on Rule 30(b)(6) deposition hours but believes Novartis' proposed limit is too short; the Court agrees with Defendants' to allow lengthier depositions of inventors; and the Court agrees with Novartis to allow lengthier depositions of expert(s) who provide opinions on both infringement and validity. With respect to the protective order, the Court believes that good cause has been shown to preclude Plaintiffs' counsel who are in receipt of Defendants' protected information from participating in the drafting, crafting, or amending of any patent claims, and the Court believes its combination of provisions proposed by both sides has resulted in a mechanism for, when needed, the sharing and potential use of one Defendant's information against another Defendant, while providing adequate protections to all parties and not unduly risking burdening the Court. Ordered by Judge Leonard P. Stark on 10/25/2018. (etg) |
| Oct 23, 2018 | 35 | Proposed ESI Order (15) |
| Oct 23, 2018 | 35 | Proposed Protective Order (33) |
| Oct 23, 2018 | 35 | Proposed Scheduling Order (26) |
| Oct 23, 2018 | 35 | Main Document (6) Docket Text: Joint Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Rule 16 Teleconference. (Attachments: # (1) Proposed Scheduling Order, # (2) Proposed Protective Order, # (3) Proposed ESI Order)(Silver, Daniel) |
| Oct 23, 2018 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Joint Requests for Production to Novartis (Nos. 60-64) filed by Bionpharma Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc., Prinston Pharmaceutical Inc..(Dorsney, Kenneth) |
| Oct 23, 2018 | 33 | Motion to Stay (2) Docket Text: MOTION to Stay re (11 in 1:18-cv-01038-LPS) MOTION to Stay Proceedings Pending The Appeal Of An IPR Decision On The Sole Patent In Suit(Joinder) - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd.. (Gattuso, Dominick) |
| Oct 23, 2018 | 32 | Transcript (39) Docket Text: Official Transcript of Telephone Conference held on October 16, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/13/2018. Redacted Transcript Deadline set for 11/23/2018. Release of Transcript Restriction set for 1/22/2019.(bpg) |
| Oct 23, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein, Eimeric Reig-Plessis, and Zachary L. Sorman for Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., and Sun Pharmaceutical Industries, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Oct 17, 2018 | 31 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Defendants' First Joint Interrogatories to Plaintiff (Nos. 1-13) and (2) Novartis's Objections and Responses to Defendants' First Joint Requests for Production to Novartis (Nos. 1-59) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Oct 16, 2018 | 30 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Jamie Lynne Brown on behalf of Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd. (Brown, Jamie) |
| Oct 16, 2018 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Discovery/Scheduling teleconference today will begin at 3:15 p.m. ORDERED by Judge Leonard P. Stark on 10/16/18. Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS (ntl) |
| Oct 16, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Discovery/Scheduling teleconference held on 10/16/2018 (Court Reporter B. Gaffigan.) Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS (ntl) |
| Oct 12, 2018 | 28 | Exhibit 1 - 4 (38) |
| Oct 12, 2018 | 28 | Main Document (5) Docket Text: Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Defendants' Response to Plaintiff's Opening Discovery Dispute Letter - re (38 in 1:18-cv-01038-LPS, 196 in 1:18-cv-01043-LPS, 27 in 1:18-cv-01039-LPS, 25 in 1:18-cv-01040-LPS) Letter. (Attachments: # (1) Exhibit 1 - 4)(Phillips, John) |
| Oct 12, 2018 | 27 | Exhibit E (10) |
| Oct 12, 2018 | 27 | Main Document (4) Docket Text: Letter to the Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Response to Defendants' October 11, 2016 Letter - re (39 in 1:18-cv-01038-LPS, 197 in 1:18-cv-01043-LPS, 26 in 1:18-cv-01040-LPS, 28 in 1:18-cv-01039-LPS) Letter. (Attachments: # (1) Exhibit E)(Silver, Daniel) |
| Oct 11, 2018 | 26 | Letter (5) Docket Text: Letter to the Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Defendants' Opening Dispute Letter. (Phillips, John) |
| Oct 11, 2018 | 25 | Exhibit A - D (78) |
| Oct 11, 2018 | 25 | Main Document (4) Docket Text: Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Disputes About the Proposed Scheduling Order and Proposed ESI and Protective Orders. (Attachments: # (1) Exhibit A - D)(Silver, Daniel) |
| Oct 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Eimeric Reig-Plessis, and Zachary L. Sorman filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE. Signed by Judge Leonard P. Stark on 10/11/2018. (etg) |
| Oct 10, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Teleconference set for 10/16/18 at 02:00 PM is RESCHEDULED for 10/16/2018 at 2:45 PM before Judge Leonard P. Stark. Ordered by Judge Leonard P. Stark on 10/10/2018. (etg) |
| Oct 10, 2018 | 23 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Eimeric Reig-Plessis, and Zachary L. Sorman - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd.. (Gattuso, Dominick) |
| Oct 9, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a discovery and scheduling teleconference is scheduled for October 16, 2018 at 2:00 p.m. Counsel for the party seeking relief shall initiate the teleconference call to 302-573-4571. IT IS FURTHER ORDERED that not later than October 11, 2018, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than October 12, 2018, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 10/9/2018. (etg) |
| Oct 4, 2018 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries, Ltd.'s, Sun Pharmaceutical Industries, Inc.'s, and Sun Pharma Global FZE's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things; and Objections and Responses to Plaintiff's First Set of Interrogatories filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd..(Gattuso, Dominick) |
| Sep 24, 2018 | 20 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding request to schedule a Rule 16 Conference. (Phillips, John) |
| Sep 18, 2018 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures and Default Standard for Discovery, Including Discovery of Electronically Stored Information (ESI), Paragraph 3 Initial Disclosures filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd..(Gattuso, Dominick) |
| Sep 17, 2018 | 18 | Letter (3) Docket Text: Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Requesting a Discovery Teleconference. (Silver, Daniel) |
| Sep 17, 2018 | 17 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) PLAINTIFFS INITIAL DISCLOSURES PURSUANT TO FED. R. CIV. P. 26(a)(1) and (2) PLAINTIFFS RULE 3 DISCLOSURES filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Sep 17, 2018 | 16 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Joint Interrogatories to Plaintiff (Nos. 1-13); and (2) Defendants' First Joint Requests for Production to Plaintiff (Nos. 1-59) filed by Biocon Limited, Biocon Pharma, Inc., Cadila Healthcare Limited, Emcure Pharmaceuticals, Heritage Pharmaceuticals Inc., Zydus Pharmaceuticals (USA) Inc..(Haney, Megan) |
| Sep 4, 2018 | 15 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Set of Common Requests for the Production of Documents and Things to All Defendants; and (2) Plaintiff's First Set of Common Interrogatories to All Defendants filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Aug 31, 2018 | 14 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures of Accused Products and Asserted Patents; and (2) The File History for the Asserted Patent filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Aug 30, 2018 | 13 | Answer to Counterclaim (12) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Aug 27, 2018 | 12 | Letter to the Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding (2) |
| Aug 27, 2018 | 12 | Main Document (19) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Letter to the Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Proposed Scheduling Order)(Silver, Daniel) |
| Aug 10, 2018 | 11 | Exhibit A-B (6) |
| Aug 10, 2018 | 11 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Sun Pharmaceutical Industries, Ltd. made on July 19, 2018 by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-B)(Silver, Daniel) |
| Aug 10, 2018 | 10 | Exhibit A-B (6) |
| Aug 10, 2018 | 10 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Sun Pharmaceutical Industries, Inc. made on July 19, 2018 by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-B)(Silver, Daniel) |
| Aug 9, 2018 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries, Ltd. for Sun Pharmaceutical Industries, Inc.; Corporate Parent Sun Pharma Holdings for Sun Pharma Global FZE filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd.. (Gattuso, Dominick) |
| Aug 9, 2018 | 8 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc..(Gattuso, Dominick) |
| Aug 7, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Robert W. Trenchard for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS(ceg) |
| Aug 1, 2018 | 7 | Acknowledgment of Service (1) Docket Text: ACKNOWLEDGEMENT OF SERVICE Executed on behalf of Defendant Sun Pharma Global FZE Acknowledgement filed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Jul 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jane M. Love for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS(dmp, ) |
| Jul 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew Blythe for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS(dmp, ) |
| Jul 24, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (6 in 1:18-cv-01039-LPS, 6 in 1:18-cv-01038-LPS, 6 in 1:18-cv-01043-LPS, 6 in 1:18-cv-01040-LPS) MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert Trenchard, Paul E. Torchia, and Andrew P. Blythe filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 7/24/18. Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS (ntl) |
| Jul 23, 2018 | 6 | Certifications for Jane M. Love, Robert Trenchard, Paul E. Torchia, and Andrew (4) |
| Jul 23, 2018 | 6 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert Trenchard, Paul E. Torchia, and Andrew P. Blythe - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifications for Jane M. Love, Robert Trenchard, Paul E. Torchia, and Andrew P. Blythe)(Silver, Daniel) |
| Jul 19, 2018 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Sun Pharmaceutical Industries, Ltd. (ceg) |
| Jul 18, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-01038-LPS, 1:18-cv-01039-LPS, 1:18-cv-01040-LPS, 1:18-cv-01043-LPS (rjb) |
| Jul 13, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (rwc) |
| Jul 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,187,405. (rwc) |
| Jul 13, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/3/16. Date of Expiration of Patent: 6/25/27. (rwc) |
| Jul 13, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Jul 13, 2018 | 1 | Civil Cover Sheet (2) |
| Jul 13, 2018 | 1 | Exhibit A-B (71) |
| Jul 13, 2018 | 1 | Main Document (10) Docket Text: COMPLAINT - filed against Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2419123.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(rwc) |
| Jul 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Sun Pharma Global FZE on 7/13/2018; Sun Pharmaceutical Industries, Inc. on 7/13/2018; Sun Pharmaceutical Industries, Ltd. on 7/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
